Trial to Evaluate the Ability of a Single Infusion of High-Density Lipoprotein (HDL) to Modulate Markers of Cerebral Ischaemia

NCT00822302 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: Reconstituted High Density Lipoprotein
DRUG: Saline

Sponsor

St George's, University of London